Hostname: page-component-8448b6f56d-sxzjt Total loading time: 0 Render date: 2024-04-24T03:30:57.288Z Has data issue: false hasContentIssue false

Measuring the unmeasurable: the role and importance of quality of life measurement in economic evaluations of sleep disorder treatment

Published online by Cambridge University Press:  16 April 2020

JM Graf von der Schulenburg*
Affiliation:
North German Centre for Health Services Research, University of Hannover, Königsworther Platz 1, 30167Hannover, Germany
Get access

Summary

Sleep disorder is a widespread chronic disease. Its treatment and the disease itself causes losses to society, eg treatment cost and cost of sick leaves. On the other hand an appropriate treatment increases patients' quality of life and work productivity. The basic methods for evaluating the costs and benefits of treating sleep disorders are described.

Type
Research Article
Copyright
Copyright © Elsevier, Paris 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Cox, DR, et al. Quality of life assessment: can we keep it simple. J R Stat Soc 1992;155:353–93CrossRefGoogle Scholar
Drummond, MTeeling Smith, GWells, N ed. Economic Evaluation in the Development of Medicines London: Office of Health Economics, 1988Google Scholar
Drummond, M, et al. Economic Evaluation of Pharmaceuticals: a European Perspective. Pharmaeconomics 1993; 4: 173–86CrossRefGoogle ScholarPubMed
Pohl, WGraf von der, Schulenburg JMHealth Care and Economics Aspects of the Quality of Life of Heart Failure Patients. In: Viefhues, eds. Chronic Heart Failure Berlin: Springer, 1991 149–64CrossRefGoogle Scholar
United States Congress. Wake up America A National Sleep Alert, Executive Summary and Executive Report of the United States Congress 1992Google Scholar
Submit a response

Comments

No Comments have been published for this article.